Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue (Q40693029)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 March 2010
edit
Language Label Description Also known as
English
Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue
scientific article published on 18 March 2010

    Statements

    Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue (English)
    Vanessa P Houde
    Sophie Brûlé
    Pierre-Gilles Blanchard
    Kerstin Bellmann
    Yves Deshaies
    André Marette

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit